NCoR1 and SMRT fine-tune inflammatory versus tolerogenic balance in dendritic cells by differentially regulating STAT3 signaling
| Main Authors: | Atimukta Jha, Abdul Ahad, Gyan Prakash Mishra, Kaushik Sen, Shuchi Smita, Aliva P Minz, V. K. Biswas, Archana Tripathy, S. S. Senapati, Bhawna Gupta, H. A. Orbea, Sunil K Raghav |
|---|---|
| Format: | info dataset Journal |
| Terbitan: |
, 2021
|
| Online Access: |
https://zenodo.org/record/4911208 |
Daftar Isi:
- Dendritic cell (DC) fine-tunes inflammatory versus tolerogenic responses to protect from immune-pathology. However, the role of co-regulators in maintaining this balance is unexplored. NCoR1-mediated repression of DC immune-tolerance has been recently reported. Here we found that depletion of NCoR1 paralog SMRT enhanced cDC141 activation and expression of IL-6, IL-12 and IL-23 while concomitantly decreasing IL-10 expression/secretion. Consequently, co-cultured CD4+ and CD8+ T-cells depicted enhanced Th1/Th17 frequency and cytotoxicity, respectively. Comparative genomic analysis demonstrated differential regulation of IL-10 by SMRT and NCoR1. SMRT depletion repressed mTOR-STAT3-IL10 signaling in cDC1 by down-regulating NR4A1. Besides, NFkBIA and SOCS3 were down-regulated in SMRT knockdown cDC1, supporting increased production of inflammatory cytokines. Moreover, adoptive transfer of SMRT knockdown cDC1 in OVA-DTH induced footpad inflammation led to increased Th1/Th17 and reduced tumor burden after B16 melanoma injection by enhancing oncolytic CD8+ T-cell frequency, respectively. We also depicted decreased Smrt expression in Rheumatoid Arthritis, a Th1/Th17 disease.